Trainline Raises FullYear Guidance for Second Time in 2026 ABC Files Early Station License Renewals Questions Legitimacy of Process EOG Resources Surges in Q1 as Oil Prices and Operational Strength Drive Investor Optimism US Productivity Growth Slows in Q4 as Unit Labor Costs Accelerate Tencent Focuses on AI Agents and Smaller Models in Competitive Landscape Against Alibaba and ByteDance White House Announces New Soybean and Rare Earths Agreements Following TrumpXi Summit China Signals Tariff Reduction HIMX Q1 2026 Earnings Slight EPS Beat Drives Positive Market Reaction Brookfield Corporation BN Q1 2026 Earnings EPS Beats Estimates Amidst Modest Stock Pullback HUT Q3 2024 Earnings EPS Surprises to the Upside as Costs Tighten AAP Q1 2026 Earnings Significant EPS Beat Amid Mixed Operational Trends KKRT Q1 2026 Earnings EPS Surpasses Expectations Amid Strong Investment Performance Gran Tierra Energy Inc Q4 2025 Earnings Net Loss Reported as Oil Producer Navigates Lower Prices Calamos Global Total Return Fund CGO Edges Higher Holding Near Resistance DT Cloud Star Acquisition Corporation DTSQ Holds Steady Near 1122 Amid Quiet Trading Quad Graphics Inc QUAD Edges Higher as Stock Tests Key Resistance Zone Emerson Radio MSN Slides 284 as Stock Tests Key Support at 042 Pimco New York Municipal Income Fund II PNI Edges Higher as YieldSeeking Investors Return Eli Lilly Expands Vaccine Portfolio with Up to 38 Billion in Deals for Three Developers OnKure Therapeutics OKUR Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Advances Pipeline FIGS Inc Edges Higher as Stock Approaches Resistance Zone Lam Research LRCX Receives Analyst Upgrades Amid Oversold Growth Stock Interest Nvidias PostEarnings Dip The Broader Context Sellers May Be Overlooking Custard Apple Exports Face Challenges Despite Hardy Plant Characteristics Quantinuum Files for IPO Quantum Computing Startup Targets 13 Billion Valuation Lowenstein Sandler Hires Scott D Fisher to Strengthen MA and Capital Markets Practice Spotify Jumps 13 After AI Music Deal with Universal Music and 2030 Revenue Guidance Arrowhead Pharmaceuticals Presents Plozasiran Data on Renal and Hepatic Impairment